Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹22.82
Market cap: ₹126.0 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 52.0×Sector 50.4×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Earnings Call 2 Other Announcement 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 13:52 IST NSE

Financial Results

Balaxi Pharmaceuticals Q1 FY27 Results: Net Profit ₹1.3 Cr, Up 333.3% YoY

Balaxi Pharmaceuticals Ltd reported revenue from operations of ₹80.7 Cr (+14.1% YoY) and net profit of ₹1.3 Cr (+333.3% YoY) for Q1 FY27.

Key figure: Net profit ₹1.3 Cr · +333.3% YoY

Open full results → Read the filing ↗

28 May 2026 19:24 IST NSE

Financial Results

Balaxi Pharmaceuticals Q4 FY26 Results: Net Profit ₹0.6 Cr, Down 93.0% YoY

Balaxi Pharmaceuticals Ltd reported revenue from operations of ₹70.7 Cr (-7.3% YoY) and net profit of ₹0.6 Cr (-93.0% YoY) for Q4 FY26.

Key figure: Net profit ₹0.6 Cr · -93.0% YoY

Open full results → Read the filing ↗